IBBR/NIST Seminar: "Facilitating the Development and Availability of COVID-19 Vaccines"
Event Type:
IBBR Seminar Series
Contact Person:
Nicole Tenly
Event Info
Date:
Monday, June 27 2022 - 11:00am to 12:00pm
Location:
Virtual
Event Details
Speaker:
Peter Marks
Affiliation:
FDA
Description:
The current global COVID-19 outbreak has challenged our public health capabilities, including the ability
to rapidly develop, evaluate, manufacture, and deploy adequate supplies of preventative vaccines.
Operation Warp Speed was developed to reduce the time to deployment of safe and effective medical
countermeasures to diagnose, treat, and prevent COVID-19. To help facilitate this process, early on
during the pandemic, the Food and Drug Administration issued guidance to help expedite the
development of COVID-19 vaccines. In the United States there are three vaccines now authorized or
approved for use across a variety of age ranges as primary series and booster doses. Given the
continued evolution of SARS-CoV-2, consideration will need to be given to booster vaccine strain
composition moving forward. Vaccine development during the pandemic had shed light on expediting
medical product development in general.
Join Zoom Meeting
https://umd.zoom.us/j/91972863109?pwd=WkllaXhrWGRwVFlycG9zTW50UDB1Zz09
Meeting ID: 919 7286 3109
Passcode: 548931
One tap mobile
+13017158592,,91972863109# US (Washington DC)
+19294362866,,91972863109# US (New York)
Dial by your location
+1 301 715 8592 US (Washington DC)
+1 929 436 2866 US (New York)
+1 312 626 6799 US (Chicago)
+1 669 900 6833 US (San Jose)
+1 253 215 8782 US (Tacoma)
+1 346 248 7799 US (Houston)
Meeting ID: 919 7286 3109